Defined Daily Dose Codes for 2018 to 2019

$447.50 / year

This dataset contains the Defined Daily Dose (DDD) 2018 to 2019. In order to measure drug use, it is important to have both a classification system and a unit of measurement. To deal with the objections against traditional units of measurement, a technical unit of measurement called the Defined Daily Dose (DDD) to be used in drug utilization studies was developed.

Complexity

In 1981, the WHO Regional Office for Europe recommended the ATC/DDD system for international drug utilization studies. In connection with this, and to make the methodology more widely used, there was a need for a central body responsible for co-ordinating the use of the methodology. The WHO Collaborating Centre for Drug Statistics Methodology was accordingly established in Oslo in 1982. The Centre is now located at the Norwegian Institute of Public Health. The Norwegian government funds the Centre.

In 1996, WHO recognized the need to develop use of the ATC/DDD system as an international standard for drug utilization studies. The Centre was therefore linked directly to WHO Headquarters in Geneva instead of the WHO Regional Office for Europe in Copenhagen. This was seen as important to allow close integration of international drug utilization studies and WHO’s initiatives to achieve universal access to needed drugs and rational use of drugs particularly in developing countries. Access to standardized and validated information on drug use is essential to allow audit of patterns of drug utilization, identification of problems, educational or other interventions and monitoring of the outcomes of the interventions.

When the decision on globalizing the ATC/DDD system was taken, the WHO Division of Drug Management and Policies established the WHO International Working Group for Drug Statistics Methodology. The WHO Collaborating Centre for Drug Statistics Methodology receives expert advice from the Working Group.

Date Created

2017

Last Modified

2017-11-28

Version

2017-11-28

Update Frequency

Semiannual

Temporal Coverage

2018-2019

Spatial Coverage

United States

Source

John Snow Labs; WHO Collaborating Centre for Drug Statistics Methodology;

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

ATC Classification, ATC/DDD, ATC Alterations, DDD Alterations, New ATC, New DDD

Other Titles

New DDD Code 2019, New ATC Update and Alterations, New DDD Updates and Alterations

NameDescriptionTypeConstraints
ATC_CodeA Unique Alpha Numeric Anatomical Therapeutic Chemical Codestring-
ATC_Level_NameAnatomical Therapeutic Chemical Code Level Namestring-
New_DDDNew Rate of Defined Daily Dose. Various Sources are used to get the Best Overview of the Actual or Expected use of a Substance.numberlevel : Ratio
UnitDDD Unit of measurement (g=gram, gm = milligramstring-
Administration_RouteRoute of administration (O = oral, P = parenteral)string-
ATC CodeATC Level NameNew DDDUnitAdministration Route
A02BX14rebamipide0.3gO
A05AA04obeticholic acid10.0mgO
A06AX07plecanatide3.0mgO
A10BF03voglibose0.6mgO
A10BH07evogliptin5.0mgO
A16AX14migalastat61.5mgO
B01AC26vorapaxar2.08mgO
B01AC27selexipag1.8mgO
B03AB09ferric proteinsuccinylate80.0mgO Fe3+
C09CA10fimasartan60.0mgO